Norwegian Institute of Public HealthOslo, Norway
Disclosure information not submitted.
Glucagon-Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study in Canada, Denmark, Norway, Sweden, South Korea and Taiwan
Tuesday, August 27, 20248:15 AM – 8:30 AM CEST
Risk of kidney stones following SGLT2i- and GLP1-RA initiation among patients with type 2 diabetes in Denmark, Norway, UK, and Taiwan: Population-based active comparator, new user cohort studies and meta-analysis
Wednesday, August 28, 20242:30 PM – 2:45 PM CEST
